Glioblastoma

Enrollment phase of INDYGO is now successfully achieved

After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial

Rare diseases foundation and OncoThAI

OncoThAI and the Photodynamic Therapy Awarded by the french Rare Diseases foundation and SATT Nord

Photodynamic Therapy and OncoThAI illustrated in Nature journal

The INDYGO clinical trial by OncoThAI described in the last issue of the Nature Journal

Myrian® Studio Challenge 2018

Third place for OncoThAI

Second annual fluorescence-guided surgery brain tumor symposium

Pr. Nicolas Reyns will present our latest breakthroughs in the glioblastoma treatment.